Recombinant HAV 3C, His tag

产品概述：HAV 3C protease from human hepatitis A virus (HAV 3C), recognizes and cleaves the following sequences: ELRTQ/S, ELRTQ/A, ELRTQ/G. We have directional protein refolding technology (LeaBioFOLD) and self-developed technology platforms for proteins covering screening and purification, engineering design, fixed-point coupling design, and dosage form development. Protein refolding is a process of recovering protein aggregates in inclusion bodies in the form of misfolded and inactive proteins expressed by prokaryotes such as Escherichia coli back into proteins with correct conformation and bioactivity under appropriate conditions in vitro. It is a key technology for biopharmaceutical companies but a major bottleneck in protein production in prokaryotic expression systems. Leading Biology has been specializing in protein refolding for many years, has a core team with over ten years of experience in this technology and rich experience in its industrialization. Our team is summarizing the experience to form an independent technological system of ours.

蛋白长度：231

表达系统：E.coli

种属：Human hepatitis A virus

标签类型：N-His

分子量：27 kDa

内毒素：< 1.0 EU per μg of the protein as determined by the LAL method.

通用名：HAV 3C

形式：Liquid

纯度：> 95% as determined by SDS-PAGE and HPLC analysis.

储存条件：Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.

储存溶液：PBS, pH 8.0

别名：HAV-3C Protease